Tag Archives: Centogene

January 2018—Qiagen and Centogene announced a collaboration and comarketing agreement to provide customers more complete sample-to-insight research and clinical testing solutions in rare genetic diseases. The collaboration includes the integration of Centogene’s CentoMD rare disease variant database into Qiagen’s bioinformatics offering to enhance test interpretation.

February 2017—Centogene, a genetics company focused on the early diagnosis of rare hereditary disorders, has introduced the Illumina HiSeq X whole genome sequencing platform …